but expect companies to select the most appropriate based on risk assessment.

What Is Swab Sampling?

Swab sampling involves wiping defined areas of equipment surfaces with a sterile swab, which is then extracted and analyzed for residues. Key features include:

• Advantages:
• Direct measurement of residues on product-contact surfaces
• Effective for hard-to-clean or worst-case locations (gaskets, crevices, corners)
• Supports ALCOA+ principles by providing traceable data from specific sites
• Limitations:
• Sample recovery efficiency may vary (typically 70–90%)
• Not feasible for large surface areas
• Technique-dependent; operator variability may affect results

Swab sampling is often preferred for worst-case, difficult-to-clean surfaces where residues are most likely to persist.

What Is Rinse Sampling?

Rinse sampling involves flushing equipment with a known volume of solvent (often water), then analyzing the rinse solution for residues. Key features include:

• Advantages:
• Can cover large or inaccessible surface areas (pipes, tanks, spray nozzles)
• Captures soluble residues that may not be detected by swabbing
• Less dependent on operator technique compared to swab sampling
• Limitations:
• Provides indirect data – cannot pinpoint the exact location of residues
• Less effective for insoluble or sticky residues
• Rinse volume may dilute residues, lowering detection sensitivity

Rinse sampling is most useful for complex equipment or when surface areas cannot be accessed for swabbing.

Audit Findings Related to Sampling Methods

Examples of regulatory observations include:

• FDA 483: Company relied only on rinse sampling for large tanks, without validating recovery efficiency or performing swab verification.
• EMA Observation: Cleaning validation did not include worst-case swab sites, relying exclusively on rinse testing.
• WHO Audit: Sampling plan lacked scientific justification for method selection; inspectors concluded it was inadequate for ensuring compliance.
• PIC/S Finding: Rinse volumes used in validation studies diluted residues below detection limits, creating false assurance.

These findings show that regulators expect a scientifically justified and balanced use of both methods.

Best Practices: When to Use Swab vs Rinse Sampling

A risk-based approach should guide method selection:

1. Use Swab Sampling When:
   • Validating hard-to-clean locations (gaskets, valves, dead legs)
   • Residues are insoluble or sticky
   • Worst-case verification of high-risk areas is needed
2. Use Rinse Sampling When:
   • Equipment has large, inaccessible areas (pipes, spray balls, tanks)
   • Residues are soluble in the rinse solvent
   • Need to verify cleanliness of areas not suitable for swabbing
3. Use Both Methods Together:
   • For critical equipment in multiproduct facilities
   • When validating new cleaning procedures
   • To strengthen scientific justification during audits

Using both swab and rinse sampling provides complementary evidence of cleaning effectiveness and satisfies regulator expectations.

Corrective and Preventive Actions (CAPA)

When deficiencies in sampling are cited, CAPA should include:

1. Updating cleaning validation protocols to include both swab and rinse methods
2. Validating recovery efficiency for swab and rinse sampling
3. Revising SOPs to specify selection criteria for sampling methods
4. Training staff on proper swabbing techniques and sampling rationale
5. Conducting retrospective risk assessments for equipment previously validated with only one method
6. Implementing routine QA oversight of sampling plans
7. Verifying CAPA effectiveness through internal audits and trending deviations

These corrective actions strengthen compliance and provide regulators with confidence in cleaning validation data.

Checklist for Internal Compliance Readiness

• Cleaning validation protocols define swab and rinse sampling clearly
• Scientific justification documented for method selection
• Validated recovery studies performed for both methods
• Swab sites include worst-case and hard-to-clean areas
• Rinse sampling volumes scientifically justified
• Analytical methods validated for sensitivity and specificity
• QA oversight includes review of sampling data
• CAPA linked to deficiencies in sampling practices
• Internal audits assess adequacy of sampling strategies
• Management reviews monitor cleaning validation performance

This checklist ensures readiness for inspections and prevents audit findings related to inadequate sampling methods.

Conclusion: Choosing the Right Sampling Strategy

Neither swab nor rinse sampling alone can fully ensure cleaning validation compliance. Swab sampling offers site-specific assurance, while rinse sampling covers larger areas and hard-to-reach surfaces. Regulators expect companies to use a risk-based approach, often combining both methods to provide robust, scientifically justified evidence. By integrating swab and rinse sampling, validating recovery efficiency, and maintaining strong documentation, companies can sustain GMP compliance, avoid audit findings, and protect patient safety.

Abbreviations

• GMP – Good Manufacturing Practice
• FDA – Food and Drug Administration
• EMA – European Medicines Agency
• WHO – World Health Organization
• PIC/S – Pharmaceutical Inspection Co-operation Scheme
• CAPA – Corrective and Preventive Action
• SOP – Standard Operating Procedure
• QMS – Quality Management System
• MACO – Maximum Allowable Carryover
• HBEL – Health-Based Exposure Limit
• PDE – Permitted Daily Exposure
• QA – Quality Assurance
• HPLC – High-Performance Liquid Chromatography
• TOC – Total Organic Carbon

References

• FDA 21 CFR Part 211
• EU GMP Guidelines (EudraLex Volume 4)
• WHO GMP Guidelines
• PIC/S Publications